Showing results (71-80 of 118) with videos related to
Sort By:
Pageof 12
BMC Medicine|July 21, 2021
Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapyJunyu Long, Dongxu Wang, Xu Yang, et al.Thoracic Cancer|February 29, 2020
Clinical diagnosis and treatment of immune checkpoint inhibitor-associated adverse events in the digestive systemYue Li, Xiaohui Kang, Hanping Wang, et al.Thoracic Cancer|December 10, 2020
Genomic characteristics of driver genes in Chinese patients with non-small cell lung cancerXiaoyan Si, Ruili Pan, Shaohua Ma, et al.Thoracic Cancer|October 29, 2024
Characterization of renal injury in non-squamous non-small cell lung cancer patients treated with pemetrexed: A single-center retrospective studyYang Wu, Kang Miao, Minjiang Chen, et al.Thoracic Cancer|November 26, 2019
Management of immune checkpoint inhibitor-related rheumatic adverse eventsJiaxin Zhou, Hanping Wang, Xiaoxiao Guo, et al.Thoracic Cancer|June 1, 2023
Analysis of cytokines in bronchoalveolar lavage fluid in patients with checkpoint inhibitor pneumonitis and pulmonary infection: A case-control studyXiaoyan Si, Xueqing Zheng, Xinlun Tian, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 26, 2019
[Clinical Diagnosis and Treatment Recommendations for the Pneumonitis Associated with Immune Checkpoint Inhibitor]Hanping Wang, Xiaoxiao Guo, Jiaxin Zhou, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 26, 2019
[Management of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors]Jiaxin Zhou, Qian Wang, Lian Duan, et al.Hepatology International|July 2, 2024
Management and treatment of severe immune-related hepatotoxicity based on clinical and pathological characteristicsNan Zhang, Zhaohui Li, Yutao Liu, et al.Cancer Medicine|November 19, 2020
Clinical characteristics and management of immune checkpoint inhibitor-related pneumonitis: A single-institution retrospective studyHanping Wang, Yanwei Zhao, Xiaotong Zhang, et al.Pageof 12